Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis
Subacute sclerosing panencephalitis (SSPE) is a late-onset, intractable, and fatal viral disease caused by persistent infection of the central nervous system by a mutant strain of the measles virus. Ribavirin intracerebroventricular therapy has already been administered to several SSPE patients in J...
Main Authors: | Koichi Hashimoto, Mitsuaki Hosoya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/2/427 |
Similar Items
-
Disease-Modifying therapy in subacute sclerosing panencephalitis: An area of darkness
by: Divyani Garg, et al.
Published: (2023-01-01) -
Subacute sclerosing panencephalitis – current perspectives
by: Jafri SK, et al.
Published: (2018-06-01) -
Unusual progression of an adult-onset subacute sclerosing panencephalitis (SSPE) in Turkey
by: Ezgi Vural, et al.
Published: (2019-01-01) -
Atypical clinical presentation of subacute sclerosing panencephalitis (SSPE)
by: Adina Roceanu, et al.
Published: (2013-09-01) -
Subacute Sclerosing Panencephalitis, a Measles Complication, in an Internationally Adopted Child
by: Daniel J. Bonthius, et al.
Published: (2000-08-01)